Best Pharmaceutical Stocks To Add to Your Watchlist – February 08th

Eli Lilly and Company, Merck & Co., Inc., and Honeywell International are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in the research, development, manufacture, and sale of pharmaceutical products such as prescription drugs, vaccines, and other medical treatments. Investors may be attracted to pharmaceutical stocks for their potential for strong growth and profitability due to the high demand for healthcare products. The performance of pharmaceutical stocks can be influenced by factors such as clinical trial results, regulatory approvals, patent expirations, and competition within the industry. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE LLY traded up $7.72 during trading on Friday, hitting $878.09. 4,421,566 shares of the company’s stock were exchanged, compared to its average volume of 4,056,943. The company has a market cap of $833.59 billion, a PE ratio of 74.99, a P/E/G ratio of 1.87 and a beta of 0.42. Eli Lilly and Company has a fifty-two week low of $711.40 and a fifty-two week high of $972.53. The company has a current ratio of 1.27, a quick ratio of 0.97 and a debt-to-equity ratio of 2.03. The stock’s 50 day moving average price is $789.87 and its two-hundred day moving average price is $843.55.

Read Our Latest Research Report on LLY

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

NYSE MRK traded down $0.79 on Friday, hitting $87.26. The company’s stock had a trading volume of 15,806,931 shares, compared to its average volume of 14,162,434. The company’s 50-day moving average is $98.72 and its 200 day moving average is $106.60. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. Merck & Co., Inc. has a 1-year low of $87.12 and a 1-year high of $134.63. The firm has a market cap of $220.73 billion, a PE ratio of 12.97, a PEG ratio of 0.83 and a beta of 0.38.

Read Our Latest Research Report on MRK

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

Honeywell International stock traded down $4.30 during mid-day trading on Friday, reaching $205.52. The stock had a trading volume of 6,694,143 shares, compared to its average volume of 3,948,731. The stock’s 50-day simple moving average is $224.52 and its 200-day simple moving average is $215.11. The firm has a market capitalization of $133.64 billion, a PE ratio of 23.60, a price-to-earnings-growth ratio of 2.55 and a beta of 1.05. The company has a debt-to-equity ratio of 1.33, a quick ratio of 1.12 and a current ratio of 1.31. Honeywell International has a fifty-two week low of $189.75 and a fifty-two week high of $242.77.

Read Our Latest Research Report on HON

See Also